Chapter 50: Alpha Capital and Amgen Biopharma

Although Silicon Valley is a representative of innovative technology, there are also a lot of venture capital companies established here!

On a financial street in San Jose, Silicon Valley, Prestige Capital was quietly established. Originally, Henry was going to name it Williams Ventures, but the name was too long and accounted for the number of words, so it was called Prestige Capital.

There is a way that people are as their name suggests, so Henry also hopes that the name of Prestige Capital can be as majestic as its name!!

The company has just been renovated, Henry came to see the effect, although the company has already been established, but it will be a while before the official opening!

Henry walked around the company a few times and was about to close the door and leave, when two people came over.

Both were middle-aged men in suits, one tall with a full beard. The other is of medium stature and wears glasses.

"May I ask you what is the matter?" asked Henry.

"This is also a venture capital firm?" asked the tall, middle-aged man.

Henry nodded, "That's right, yes, it's a newly formed venture capital firm. ”

"Newly formed?" the two looked at each other, expressions of disappointment.

The two of them are the founders of Amgen Biopharmaceuticals, Dr. Rothman with glasses, and his partner, Tony Lambert, the taller man. After nine years from its establishment in 1980 to June 1989, Amgen finally developed its first product, "Recombinant Human Erythropoietin" (EPO), which has been approved by the US FDA for the treatment of anemia caused by chronic renal failure and anemia for the treatment of HIV infection. However, the fate of the EPO was bumpy, the promotion was unfavorable, and Amgen was suddenly unsustainable, and at this time, the Johnson & Johnson Group took advantage of the fire to rob and wanted to buy out all the overseas sales of the EPO for 19 million! Of course, Amgen Biopharmaceutical Company did not do it, so it looked everywhere for investment!

However, there is little hope!

After nine years of grinding a sword, grinding and grinding, and finally grinding the product to come out, but still not making money, which investor dare to invest in it?!!

Dr. Rothman and Tony Lambert ran into a wall and a dirty face. Just when they were desperate and wanted to agree to Johnson & Johnson's request, they accidentally ran into a venture capital firm and thought, they have to try it anyway, even if they will be rejected in the end!

So, there was this meeting!

However, when they heard that the venture capital firm had just been established, they were immediately disheartened. No new venture capital firm would dare to take such a big risk to invest in Amgen Biopharma! However, Rothman and Lambert had no idea that this meeting would change their lives and change the future of Amgen Biopharma!!

In the previous life, Amgen Biopharmaceutical Company was robbed by Johnson & Johnson, resulting in most of the company's early profits being put into Johnson & Johnson's pocket. But even so, Amgen Biopharma has grown to become one of the top biopharmaceutical companies in the world, with a market capitalization of more than 100 billion yuan in the fields of human genomics, cancer, neuroscience and small molecule chemistry!

Maybe you can't find a genetic evolution potion!

Henry asked them who they were, and when he heard their reply, although Henry's face was silent, his heart was already shocked!

"Your company is planning to raise money?" asked Henry, pretending to be calm.

"Yes!" the two nodded.

Henry invited them into the house and sat down, smiled at the two of them, and said, "It seems that we are very fateful! You are the first customer to come to the door, so no matter what, we have to invest in your company more or less!!

Rothman and Lambert looked at each other with surprise on their faces.

Henry poured water for them and asked, "Tell me, how much are you going to want?"

The two of them suddenly fell silent, wondering how much it would be appropriate. If you want too much, others will definitely not give it. Less, for the company, it is a drop in the bucket. The two have been hit so hard lately that none of the venture capital firms are willing to invest in them. But now that I have it, I'm afraid that I'll talk too much and scare others away!!

After half a ring, Rothman said tentatively, "Ten million?"

At this moment, as soon as the words fell, Henry's body leaned forward in vain. Seeing this, Rothman suddenly became nervous, and hurriedly shook his head and said, "Eight million is fine!!"

"Yes, yes, it's okay to invest eight million in us!" Lambert said hurriedly.

Henry was speechless, and the reason I leaned forward was because you really wanted too little...... With such a small investment, how can I get more shares?!! alas, I just leaned forward to see what scared you......

"Well, I'll invest $100 million in your company and get an 80% stake!" said Henry, pretending to be a fucked man.

"No, no, we don't need to invest so much!" The two felt like they were on a roller coaster, and the gap was too big for them to be pleasantly surprised! However, they also understood that the company had great potential for development, and they were definitely unwilling to sell too many shares.

"In that case......," Henry thought for a moment, then asked, "Have you ever received venture capital?"

"When we started the company, the venture capital firm invested 19 million dollars in us!"

"And how many shares do they have?"

“45%。 ”

"Hehe, that's going to be easy!" Henry smiled, "You see if this will work, you go and persuade them to sell me all the shares, and then I will raise money for your company!"

Rothman and Lambert glanced at each other, exchanged words in a low voice, and finally nodded: "No problem, I can help you persuade you, but I can't guarantee whether they will sell shares or not!"

"Don't worry, they'll sell!" said Henry, confidently.

Amgen Biopharma can simply treat investors as if they have taken chronic poison, for nine years, you have been burning money, but the product comes out, but it can't be sold, and the company is about to go bankrupt!

In this tragic situation, you are an investor, and you must not sell your shares to cash out?!

After Rothman and Lambert walked out of the gate of Majestic Capital, the two talked to each other.

"Lambert, do you think this company is a leather bag company, do you really want to invest in us?" Rothman said with some skepticism.

Lambert's brow furrowed slightly, "I'm not sure either! I'll see later, let's investigate this company!"

Soon after, Rothman and Lambert found the information of Weifeng Capital through certain channels: "Weifeng Capital was officially registered on July 1, 1989, registered in San Jose, California, with a registered capital of 500 million US dollars. However, the legal person is an offshore company!"

"Many companies like to engage in offshore companies, which can not only evade taxes, but also hide the identity of shareholders. However, it doesn't matter who the legal person is, as long as Weifeng Capital has money!" Rothman said.

"That's right. Lambert replied, "Then let's go and persuade those investors now!"

Rothman nodded.

A week has passed, and Henry can't wait, is there something wrong in the middle?

Shouldn't it? Not in a previous life......

Henry nervously paced around the office, wondering if he should reach out to them.

At this moment, the phone rang, and it was Rothman.

"Hello, I'm Rothman, CEO of Amgen Biopharmaceuticals!"

"Oh, Dr. Rothman, hello, how are they, are they willing to give up their shares?" said Henry, trying to keep his tone calm, but he was nervous inside.

"They are willing to give up their shares, but the price may be on the high side......"

"How much do they want?"

"100 million!" Rothman said, "they said, for 100 million dollars, they're willing to give you all the shares!"

"I agreed......"

Rothman didn't expect Henry to say yes, and began to persuade him, "Mr. Williams, I know it might be a bit much, but ......"

It was only in the middle of his sentence that he finally reacted, "What!!, Mr. Williams, you actually agreed?!!"

"Yes, I agreed. I'm willing to pay $100 million to buy their shares, and then raise another $50 million into the company to hold 70% of the shares, what do you think?"

Rothman swallowed, shocked for a moment, "Okay!

As soon as Henry heard this, he knew that it was done, and that it might not be long before he became the boss of the world's top high-tech biopharmaceutical company!!

Three days later, when Henry took out two checks, one for $100 million and one for $50 million, signed a contract with Amgen Biopharma's venture capitalists and Rothman, Amgen Biopharma finally belonged to Henry's industry! Henry was very unfamiliar with biotechnology, but it didn't matter, Henry could provide funds, connections, publicity and other resources to Amgen Biopharma Company of great help. With Henry, Amgen Biopharma is at least better than in its previous life!

I just don't know how far Amgen Biopharma will develop with Henry's joining? If it can make a breakthrough in genes, engage in black technology, develop genetic evolution drugs, and make yourself superhuman or something!!, it will be awesome (depressed, I'm about to fall out of the "new authors and new books list", please support, top it!)

;